BioSpace News Archive

Glaucoma is one of the key causes of blindness, and millions of people suffer with visual impairment from glaucoma with a high incidence in those older than 65 years.

Excision BioTherapeutics Inc. announced that Excision Management will present at the following upcoming investor conferences.

Braxia Scientific Corp. (“Braxia Scientific”, or the “Company”), (CSE: BRAX) (OTC: BRAXF) (FWB: 4960), a medical research and telemedicine company with clinics providing innovative ketamine and psilocybin treatments for depression and related disorders, is pleased to announce its participation at the H.C. Wainwright Global Annual Global Investment Conference.

Sensus Healthcare, Inc. announces that management will present a company overview at the H.C. Wainwright 24th Annual Global Investment Conference being held September 12-14, 2022.

Kazia Therapeutics Limited (NASDAQ: KZIA; ASX: KZA), an oncology-focused drug development company, is pleased to announce that CEO, Dr James Garner, will be presenting at the upcoming 24th Annual Global Investment Conference, held in New York, NY, from 12 – 14 September 2022.

Vistagen Therapeutics, Inc. announced that Chief Executive Officer, Shawn Singh, will participate in the following upcoming investor conferences in New York.

Stevanato Group S.p.A. announced that management will present at the Bank of America Global Healthcare Conference in London at 9:05 a.m. on September 15, 2022.